Interleukin-10 release related to cardiopulmonary bypass in infants undergoing cardiac operations
- PMID: 8601968
- DOI: 10.1016/s0022-5223(96)70306-9
Interleukin-10 release related to cardiopulmonary bypass in infants undergoing cardiac operations
Abstract
To evaluate cytokine balance related to cardiopulmonary bypass, we prospectively investigated 11 infants undergoing cardiac operations for congenital heart disease. Proinflammatory cytokines (tumor necrosis factor-alpha and interleukin-8) and the antiinflammatory cytokine interleukin-10 were measured at multiple time points before, during, and after bypass. Tumor necrosis factor-alpha and interleukin-8 values were within normal range before the operation. These values increased significantly during bypass, reaching their peaks after protamine administration (tumor necrosis factor-alpha, 133.6 +/- 124.9 pg/ml; mean +/- standard deviation; p<0.005) and 2 hours after termination of the procedure (interleukin-8, 92.1 +/- 44.1 pg/ml; p < 0.01). Tumor necrosis factor-alpha and interleukin-8 equaled normal prebypass values from the first postoperative day on. Interleukin-10 levels were within normal range before the operation and were already significantly increased 10 minutes after initiation of bypass (interleukin 10, 39.4 +/- 34.3 pg/ml; p<0.05). These levels remained elevated throughout the procedure but returned to normal after protamine administration. A second significant release of interleukin-10 occurred from the early postoperative period on, reaching its peak 24 hours after termination of cardiopulmonary bypass (interleukin-10, 351.6 +/- 304.0 pg/ml; p < 0.01). Interleukin-10 values were normal on the second postoperative day in all patients. Interleukin-10 kinetics showed an inverse pattern compared with tumor necrosis factor-alpha and interleukin-8. This difference suggests an interplay between proinflammatory and antiinflammatory cytokines released during and after cardiopulmonary bypass. Interleukin-10 levels measured 4 and 24 hours after bypass strongly correlated with the degree of hypothermia during bypass (Spearman's correlation coefficient, -0.77 [p < 0.01] and -0.89 [p < 0.0005], respectively); these levels did not correlate with duration of bypass and aortic crossclamping, however. This result suggests that besides immunologically mediated production of interleukin-10, hypothermia itself could modulate interleukin-10 production. In conclusion, this study demonstrates interleukin-10 production, in addition to interleukin-8 and tumor necrosis factor-alpha synthesis, in response to cardiopulmonary bypass in infants. Interleukin-10 could play a protective role by down-regulating proinflammatory cytokine release during and after cardiopulmonary bypass.
Similar articles
-
Human cytokine responses to cardiac transplantation and coronary artery bypass grafting.J Thorac Cardiovasc Surg. 1996 Feb;111(2):469-77. doi: 10.1016/s0022-5223(96)70458-0. J Thorac Cardiovasc Surg. 1996. PMID: 8583822 Clinical Trial.
-
Tumor necrosis factor-alpha production in whole blood after cardiopulmonary bypass: downregulation caused by circulating cytokine-inhibitory activities.J Thorac Cardiovasc Surg. 2002 Sep;124(3):608-17. doi: 10.1067/mtc.2002.122300. J Thorac Cardiovasc Surg. 2002. PMID: 12202878
-
Circulating cytokines in patients undergoing normothermic cardiopulmonary bypass.J Thorac Cardiovasc Surg. 1994 Oct;108(4):636-41. J Thorac Cardiovasc Surg. 1994. PMID: 7934096
-
Myocardium is a major source of proinflammatory cytokines in patients undergoing cardiopulmonary bypass.J Thorac Cardiovasc Surg. 1996 Sep;112(3):806-11. doi: 10.1016/S0022-5223(96)70068-5. J Thorac Cardiovasc Surg. 1996. PMID: 8800171
-
Serum levels of interleukin-6, interleukin-8, interleukin-10, and tumor necrosis factor-α, renal function biochemical parameters and clinical outcomes in pediatric cardiopulmonary bypass surgery.Perfusion. 2019 Nov;34(8):651-659. doi: 10.1177/0267659119842470. Epub 2019 Apr 26. Perfusion. 2019. PMID: 31027462
Cited by
-
Randomized trial of the Terumo Capiox FX05 oxygenator with integral arterial filter versus Terumo Capiox Baby RX05 and Terumo Capiox AF02 arterial filter in infants undergoing cardiopulmonary bypass.J Extra Corpor Technol. 2011 Dec;43(4):207-14. J Extra Corpor Technol. 2011. PMID: 22416600 Free PMC article. Clinical Trial.
-
Changes in platelet aggregation during cardiopulmonary bypass: comparison of poly-2-methoxyethylacrylate and heparin as a circuit coating material.J Artif Organs. 2005;8(1):41-6. doi: 10.1007/s10047-004-0280-x. J Artif Organs. 2005. PMID: 15951979
-
Multiplex serum cytokine immunoassay using nanoplasmonic biosensor microarrays.ACS Nano. 2015;9(4):4173-81. doi: 10.1021/acsnano.5b00396. Epub 2015 Mar 23. ACS Nano. 2015. PMID: 25790830 Free PMC article.
-
Antibody-modified conduits for highly selective cytokine elimination from blood.JCI Insight. 2018 Jul 12;3(13):e121133. doi: 10.1172/jci.insight.121133. JCI Insight. 2018. PMID: 29997301 Free PMC article.
-
Prevention of infectious complications after heart surgery in children: procalcitonin-guided strategy.Kardiochir Torakochirurgia Pol. 2014 Jun;11(2):140-4. doi: 10.5114/kitp.2014.43840. Epub 2014 Jun 29. Kardiochir Torakochirurgia Pol. 2014. PMID: 26336411 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical